Grateful to
@JohnsHopkinsSPH
for arranging a small-group session with Dr Tony Fauci.
Easy to lose sight in current discourse, that he is an incredible scientist, being one of 50 most cited researchers worldwide for past 2 decades.
I, like many before, read Harrison's textbook!
Extremely grateful to have crossed 1000+ citations at 6 months after finishing medical school, made possible via multicenter prospective studies.
Critical enablers were extramural collaborations, writing partners, and mentors.
(Limitations of Google Scholar acknowledged).
@LabListon
@FromPhDtoLife
One can shift from one H1B or J1 visa employer to another in the US without going back to home country.
These make up the vast majority of work visas for postdocs.
The new employer issues one a new DS2019 or similar document.
Incredibly grateful to be graduating from >100-year old medical school (T10 in India) with the highest possible honors & being one of the 5 students in the university's history who received all 3 of
Hewett Medal,
Chancellor's Medal, &
University Honors.
Grateful to work with
@Medscape
on recent spate of cheating in USMLE.
Link:
Scores of some IMGs have been invalidated. Still, 3 ongoing issues of patient safety, fairness, & public trust.
@drsaqibgul
@jbcarmody
@MedscapeStudent
2023-24 Sommer Scholars webpage finally up
Growing up in India, there was always a dream of studying
@JohnsHopkins
, but costs felt so out-of-reach.
Grateful to have been 1/12 worldwide recipients this year of Sommer Scholarship (>100k)
@JohnsHopkinsSPH
Grateful to Almighty for a successful 2022
✅Completed med school & internship from India (with rank 1/250)
@kgmuindia
✅Got 50 papers in PubMed & 800+ citations
✅Moved to US for neuro-oncology research at
@MiamiCancerInst
under
@BrainTumorDoc
✅Completed 1 year of marriage!
Grateful to
@spinesection
for helping highlight our global spine surgery work on good operative outcomes of primary spine IDEM tumors.
17-year, single surgeon series from India, all symptomatic cases,
no neuromonitoring available.
@MiamiCancerInst
@Vinay_Neuro
#Neurosurgery
2021 WHO Classification of CNS Tumors released - clearly, a classification directed for developed nations, definitely not one for "WORLD" "HEALTH".
Some issues from the frontlines of LMIC:
1/n
Just published in “Frontiers in Public Health”, a 4000-word, months-long labor of love:
“Delivering High-Quality, Equitable Care in India: An Ethically-Resilient Framework for Healthcare Innovation After COVID-19“,
with
@hypermpathicdoc
Grateful to
@NASSspine
for the opportunity to serve on NASS guidelines committee for 2023-26.
Excited to contribute through best practice advocacy in evidence synthesis and guideline methodology learnt in INGUIDE program
@HEI_mcmaster
@gin_member
@INGUIDE_Program
Thank you for having the courage to state this. Certain small geographical regions or schools have clustering of scores that are 3 SD above the mean.
The statistical likelihood of such clustering occurring naturally is well below 1%.
@ECFMG_IMG
1) It's 2023 and we all still pretend as if no one uses leaked questions for their USMLE exams and get surprised, shocked at seeing insanely high 280s, 270s which have become more frequent than ever despite the exams getting tougher and tougher...
Superstar Ahmad Ozair
@NeuroAhmad
presenting safety and feasibility of ruxolitinib in high grade gliomas
@CNS_Update
. Looking forward to the phase 2 trial launching in 2024.
Congrats to all team members
@BrainTumorDoc
@yasmeenrauf
Honored to see this international collaborative work on international women leaders in
#neurosurgery
, as a co-first author, published in March 2021 issue of
@TheJNS
NS Focus.
These pathbreaking women emerged victorious against incredible discrimination!
Grateful to have our book chapter published - “Pediatric brain tumors, incorporating the latest WHO 2021 CNS5 classification! Under mentorship of Dr Nanda, Chair
@RUNeurosurgery
and! Free to read: (APC waived) with
@the_nEuRiUM
@VivekBhatMBBS
#neurosurgery
Intracranial Hypertension outcomes from the international SYNAPSE-ICU study, where I had the opportunity to provide data from Indian setting, is now out in
@yourICM
, led by
@chiara_robba
&
@Dr_Cit
!
Full paper
#Neurosurgery
@ESICM
New Global
#Neurosurgery
Paper
Our work on State of Accredited Endovascular Neurosurgery Training in India in 2021: Challenges to Capacity Building in Subspecialty Neurosurgical Care
with
@sschaganty
@rahman_faique
Free to read
+Supplementary Material
@ArifSohab
Well-said. Unfortunately, when so much is at stake, unmatched students must accept the little that is being offered, now true also for unmatched US-MD, while historically having been true for IMGs. Most IMGs do unpaid research, most at least for months till PI decides to pay.
Grateful to
@doximity
for the nice badges, and the wonderful mentors & collaborators that enabled nearly of it.
Excited to continue working in evidence synthesis, meta-research, and clinical trials in neuro-oncology and surgical outcomes.
Our Cochrane Review Protocol (with
@richrichigo
,
@VivekBhatMBBS
) on "Antibiotics in Irritable Bowel Syndrome" is out now, having gone through over 50 individual comments (& revisions) from reviewers, copyeditors & editors of
@CochraneGut
@CochraneLibrary
Packed hall for the incredible Amal Cooley’s session
@George_And_Amal
today at
@CNS_Update
#CNS23
Dr
@MartinaStippler
: How do you pick your cases?
Amal: I pick up my cases based on solely one criteria: IMPACT!
Hence I chose Aljazeera’s case of imprisoned journalists.
#CNS2023
So grateful to have had the opportunity to peer-review manuscripts 70 times to date. (& bit chuffed to hit 97th percentile on Publons).
Going over others' works does make one a better editor of their own work.
Retrospective, multi-center study examines risk of radiation necrosis when stereotactic radiosurgery and immune checkpoint inhibitors are administered concurrently in brain metastases from non-small cell lung cancer.
@DianaNwokoye
Yes there are neurosurgery positions but they are generally called pre residency fellowships and they typically fill outside the match. Key ones are at U of Iowa, Boston univ, Loma Linda, Mt Sinai, Univ of Minnesota (only ACGME accredited one).
💡 🧠 Dr. Manmeet Ahluwalia (
@braintumordoc
) discusses the impact of the phase 2 trial of nivolumab plus standard-dose or low-dose bevacizumab for recurrent
#glioblastoma
with a group of fellows in training
#ASCO24
@ASCO
Grateful to see our work, with
@Vinay_Neuro
, online in
@WorldNeurosurg
in "Doing More with Less" category, where we describe, from an Indian resource-limited setting, on a novel technique for managing postsurgical discitis.
#Neurosurgery
Grateful to
@BrainTumorDoc
for the opportunity to contribute to publication of this US multicenter clinical trial of TRC105 (carotuximab), an endoglin (CD105) inhibitor, for bevacizumab-refractory glioblastoma patients.
Just out in
@CommsMedicine
Come see our work on pediatric TBI in developing nations at the data blitz session, at the annual meeting of NNS & AANS/CNS Joint Section on Neurotrauma.
Session starting now!
@Neurotrauma
@AANSCNStrauma
#Neurosurgery
👏 Check out the Top 10 Cited Papers in 2023 in the Section “Molecular Cancer Biology”
🔉 Section “Molecular Cancer Biology” is open for submissions.
#molecularbiology
#cancers
Excited to announce e-publication of my first open access book chapter (grateful for 100% fee waiver)!
We discuss the impact of the pandemic on medical students specifically & the resilience they displayed globally.
@IntechOpen
#medicaleducation
#MedEd
Insightful conversations today with former US surgeon-general
@JeromeAdamsMD
on prudent decision-making, minority enrollment in clinical trials, & representation.
Every week, a profound experience, at
@JohnsHopkinsSPH
courtesy of Sommer Scholarship!
New hot off the press !
@PituitarySoc
@TheLancetEndo
Proposed comprehensive classifications for
#pituitary
#adenomas
for both unresected and resected adenomas...semi-quantitative scoring system easily applied in the clinic.Share Link free for 1 month:
An overview of the landscape after USMLE Pass/Fail conversion, covering scoring-related literature published till 2022.
Just out, after a year in-review
@JMIR_MedicalEd
, with
@VivekBhatMBBS
&
@DetchouDon
.
Free to read comprehensive summary
#MedTwitter
Epidemiology courses in many graduate programs (MD/MPH/MSc) fail to go beyond hypothetical examples & enumeration of various types of bias.
Simply teaching people terminology likely does little.
Impactful learning instead when instructors dissect papers in top-tier journals!
Grateful to have been a part of the multicenter TUTOR trial, investigating combo of Tucatinib + Trastuzumab + capacetabine with SRS for HER2+ breast cancer brain Mets.
Trial presented at
@EANOassociation
#EANO2023
by
@BrainTumorDoc
Read Abstract at ?
For low-grade gliomas, what are the current paradigms in DNA methylation & histone modification?
What potential clinical targets exist?
Our review in
@cancers_MDPI
with
@VivekBhatMBBS
@BrainTumorDoc
@Rrkotecha
explores these questions!
Free to read:
1) It's 2023 and we all still pretend as if no one uses leaked questions for their USMLE exams and get surprised, shocked at seeing insanely high 280s, 270s which have become more frequent than ever despite the exams getting tougher and tougher...
“Trials During Turnover” series by
@NASBSorg
with upcoming session on trial led by Dr Priya Kumthekar of tumor treating fields for recurrent meningiomas.
#NASBS
#NASBS2024
#neurosurgery
Congrats to Ahmad Ozair
@NeuroAhmad
. Next Saturday we will give away another copy
@ThiemeNY
. Retweet and Follow for a chance to be randomly selected.
Thank you
@NeuroOncSurgery
for highlighting our work, along with the fantastic new certification pathway by ABNS! Previously, several Indian neurosurgeons have had to redo 5-6 years of residency training in order to become US Board Certified.
On
#NationalWomenPhysiciansDay
, reflecting on the giants that have come before us and made medicine & our respective subfields better, below is our work in
@TheJNS
describing the sacrifices and life choices made by Asia's first female neurosurgeon.
I will be presenting at SFN Global Connectome 2021 initial results from our systematic review on 'Role of Transthyretin in Alzheimer's Disease'.
11 am, Jan 11, 2021 at session P107.
Register now at:
#SfNConnectome21
@NeuronlineSfN
@SfNtweets
Are you interested in neurosurgery and neuroscience? Would you like to learn more about neurotrauma, hydrocephalus, or neuro-oncology?Or would you like to gain a better insight into a life of a neurosurgeon?
Out in
@AcadMedJournal
, our work (free-to-read) describing how multicentric longitudinal studies looking at decline of empathy during medical school need to be done outside the US.
Such studies have, till date, only been done in US.